AMAG Pharmaceuticals to Buy Stem Cell Company for $700 Million – Bloomberg
Boston Business Journal |
AMAG Pharmaceuticals to Buy Stem Cell Company for $700 Million
Bloomberg AMAG Pharmaceuticals Inc., a specialty drug company, said it will acquire Cord Blood Registry for $700 million to expand its maternal health business. CBR houses more than 600,000 preserved umbilical cord blood and tissue stem cell units, more than … Amag Pharmaceuticals to buy stem cell bank for $700 mln AMAG Pharma (AMAG) to Acquire Cord Blood Registry in $700M Deal GTCR Announces Sale of Cord Blood Registry to AMAG Pharmaceuticals |
